{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-003336","form_type":"8-K","ticker":null,"cik":"0001504167","company_name":"TREX WIND-DOWN, INC.","filed_at":"2024-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.365344+00:00","generated_at":"2026-06-06T19:59:24.189156+00:00","sec_items":["1.01","2.01","1.03","5.02"],"event_type":"m_and_a","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Timber Pharmaceuticals completes asset sale to LEO Pharma for $14.35M in Chapter 11","bullets":["Bankruptcy Court approved the asset sale on Jan 22, 2024; closing occurred same day.","Purchase price of $14.35M; $13.9M paid via credit bid of outstanding DIP loan.","LEO Pharma acquired substantially all assets including TMB-001 under stalking horse agreement.","CEO John Koconis, CFO Joseph Lucchese, and CMO Alan Mendelsohn resigned; join LEO entity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-003336","json":"https://secwatch.observer/filing/0001493152-24-003336.json","markdown":"https://secwatch.observer/filing/0001493152-24-003336.md","text":"https://secwatch.observer/filing/0001493152-24-003336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T19:59:24.189156+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2429db89b2","claim":"John Koconis resigned as Chief Executive Officer, President and Chairman of the Board at TREX WIND-DOWN, INC..","evidence_excerpt":"Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer, President and Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"6df2352de1","claim":"Joseph Lucchese resigned as Chief Financial Officer, Treasurer and Secretary at TREX WIND-DOWN, INC..","evidence_excerpt":"Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer, Treasurer and Secretary"}],"fact_type":"executive_change"},{"claim_id":"ce29b8da19","claim":"Alan Mendelsohn departed as Chief Medical Officer at TREX WIND-DOWN, INC..","evidence_excerpt":"Also effective as of the closing of the Asset Sale, Alan Mendelsohn, Chief Medical Officer, no longer serves as Chief Medical Officer of the Company and any other positions with the Company’s subsidiaries, as applicable and has been offered employment with LEO Spiny Merger Sub, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"no longer serves"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"bf21b25c461a32522a3702bb4d4476ad14efa811","claim":"TREX WIND-DOWN, INC. completed a disposition involving LEO Pharma A/S for $14.35 million (closed 2024-01-22).","evidence_excerpt":"Agreement. the Debtors agreed to sell substantially all of the assets of the Company and its subsidiaries, including TMB-001, to LEO (the “Asset Sale”), for a purchase price of $14.35 million (the “Purchase Price”) plus the assumption of certain liabilities, subject to approval by the Bankruptcy Court and other agreed-upon conditions. On January 22, 2024, the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"LEO Pharma A/S"},{"label":"Consideration","value":"$14.35 million"},{"label":"Closing","value":"2024-01-22"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}